Side-by-side comparison of AI visibility scores, market position, and capabilities
Clinically validated XR therapeutic applications with FDA 510(k) clearances for rehabilitation and mental health. Boston MA; founded 2016; covers stroke recovery, TBI, Parkinson's, autism, and PTSD; prescribable by licensed clinicians and billable through health insurance plans.
XRHealth is a digital therapeutics company headquartered in Boston, Massachusetts, that develops clinically validated extended reality (XR) applications for medical rehabilitation and mental health treatment. Founded in 2016, XRHealth holds FDA 510(k) clearances for several of its XR therapeutic applications, a distinction that separates it from general wellness VR products and enables its applications to be prescribed by licensed clinicians and billed through health insurance. The company's platform spans rehabilitation for neurological conditions (stroke recovery, traumatic brain injury, Parkinson's disease), musculoskeletal rehabilitation, and cognitive and mental health interventions, all delivered through consumer-grade VR headsets in clinical settings or the patient's home.\n\nXRHealth's platform combines therapeutic XR applications with a clinical intelligence layer that captures patient performance data during each session—motion range, reaction time, cognitive accuracy, and engagement metrics—and presents it through a clinician portal for remote monitoring and treatment plan adjustment. This telehealth-integrated model enables physical therapists, occupational therapists, and neurologists to prescribe XR therapy programs and monitor patient progress asynchronously, extending the reach of rehabilitation services beyond clinic walls. The company partners with hospital systems, rehabilitation centers, and insurance providers to integrate XR therapy into standard care pathways.\n\nXRHealth competes with AppliedVR, Penumbra's REAL System, and MindMaze in the clinical XR therapeutics market. Its FDA-cleared product portfolio, insurance reimbursement progress, and clinician-facing data platform distinguish it from consumer wellness VR tools and position it as a credentialed medical technology company. For healthcare providers and payers seeking technology-enabled rehabilitation solutions that can demonstrate clinical outcomes and integrate into existing care management workflows, XRHealth offers one of the most clinically validated XR therapy platforms commercially available.
Top-3 global iGaming content provider; releases 7–8 new slot titles monthly, powers live casino for 300+ operators. Combined revenue with Evolution exceeded $5.2B in 2024.
Pragmatic Play is a leading B2B iGaming content provider founded in 2015 and headquartered in Sliema, Malta. The company develops and licenses online slots, live casino, virtual sports, and bingo products to online casino operators worldwide. Pragmatic Play is best known for its high-volume slot output—releasing an average of 7–8 new titles per month—and for iconic games including The Dog House, Gates of Olympus, Sweet Bonanza, and Wolf Gold. Its live casino product competes directly with Evolution, with dedicated studios in Romania, Gibraltar, and the Bahamas.\n\nPragmatic Play operates a fully managed service model for smaller operators, providing a turnkey suite including games, platform, and promotional tools. For larger operators, it licenses content and live casino streams under revenue-share or fixed-fee agreements. The company holds gaming licenses in 25+ regulated jurisdictions including the UK, Malta, Gibraltar, New Jersey, and Ontario. Its B2B client roster includes 300+ operators across Europe, Latin America, and North America.\n\nPragmatic Play commands approximately 25% of the global live casino B2B market (behind Evolution at 45%) and is the world's most prolific slot developer by release volume. The company does not disclose standalone financials but is estimated to generate $1B+ in annual net revenue. Pragmatic Play and Evolution together accounted for the majority of the $5.2B+ combined iGaming content revenue in 2024, with projections suggesting the combined market grows to $7.1B by 2026.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.